Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
August 29, 2021 at 01:36 pm IST
Share
Zhejiang Tailin BioEngineering Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 111.038 million compared to CNY 86.201 million a year ago. Operating income was CNY 30.769 million compared to CNY 18.536 million a year ago. Net income was CNY 27.653 million compared to CNY 18.295 million a year ago. Basic earnings per share from continuing operations was CNY 0.53 compared to CNY 0.37 a year ago.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 
